Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google. Opens in new tab
ENTITY
Divi's Laboratories (DIVI IN)
Watchlist
99
Analysis
Health Care
•
India
Divi's Laboratories Ltd. manufactures pharmaceutical products which include generic drugs and their intermediates. The Company also undertakes contract research activities for other pharmaceutical companies.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
HDFC Bank
•
30 Jul 2024 07:32
India: Potential Free Float Changes & Passive Flows in August
Changes to shareholding patterns could lead to changes in float for some stocks in local/global indices. Passive trackers will need to trade over 4...
Brian Freitas
Follow
609 Views
Share
bearish
•
Berger Paints India
•
30 Jul 2024 00:10
NIFTY100 Low Volatility 30 Index Rebalance Preview: Four Changes in September
Four constituent changes, volatility changes and capping changes will result in one-way turnover of 16% resulting in a one-way trade of INR 6.71bn...
Brian Freitas
Follow
395 Views
Share
bullish
•
JSW Energy Ltd
•
28 Jul 2024 23:09
NIFTY NEXT50 Index Rebalance Preview: 7 Changes as Non-F&O Stocks Replace F&O Members
There could be 7 changes for the Nifty Next 50. The addition of non-FnO stocks and deletion of FnO stocks raises index replication issues. Expect...
Brian Freitas
Follow
421 Views
Share
bullish
•
Akums Drugs and Pharmaceuticals
•
26 Jul 2024 14:17
Akums Drugs and Pharmaceuticals IPO: Subscribe on Favorable Industry Tailwind and Reasonable Pricing
Akums Drugs and Pharmaceuticals, has set IPO price band at Rs 646–679 per share, seeking a P/E valuation of 28.7–30.2x, which seems to be...
Tina Banerjee
Follow
585 Views
Share
bullish
•
Akums Drugs and Pharmaceuticals
•
26 Jul 2024 05:00
Akums Drugs and Pharmaceuticals IPO - RHP Updates & Quick Thoughts on Peer Comp and Valuation
Akums Drugs and Pharmaceuticals is looking to raise up to US$222m in its upcoming India IPO. In this note, we talk about its RHP updates and share...
Ethan Aw
Follow
481 Views
Share
First
Previous
6
7
8
9
10
11
12
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.10
x